68 related articles for article (PubMed ID: 8782831)
1. Identification of NF1 mutations in both alleles of a dermal neurofibroma.
Sawada S; Florell S; Purandare SM; Ota M; Stephens K; Viskochil D
Nat Genet; 1996 Sep; 14(1):110-2. PubMed ID: 8782831
[TBL] [Abstract][Full Text] [Related]
2. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation.
Upadhyaya M; Huson SM; Davies M; Thomas N; Chuzhanova N; Giovannini S; Evans DG; Howard E; Kerr B; Griffiths S; Consoli C; Side L; Adams D; Pierpont M; Hachen R; Barnicoat A; Li H; Wallace P; Van Biervliet JP; Stevenson D; Viskochil D; Baralle D; Haan E; Riccardi V; Turnpenny P; Lazaro C; Messiaen L
Am J Hum Genet; 2007 Jan; 80(1):140-51. PubMed ID: 17160901
[TBL] [Abstract][Full Text] [Related]
3. Translating current basic research into future therapies for neurofibromatosis type 1.
Brosseau JP; Liao CP; Le LQ
Br J Cancer; 2020 Jul; 123(2):178-186. PubMed ID: 32439933
[TBL] [Abstract][Full Text] [Related]
4. The Contribution of Oxidative Stress to
Kuhn E; Natacci F; Corbo M; Pisani L; Ferrero S; Bulfamante G; Gambini D
Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627552
[TBL] [Abstract][Full Text] [Related]
5. RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights.
Rhodes SD; McCormick F; Cagan RL; Bakker A; Staedtke V; Ly I; Steensma MR; Lee SY; Romo CG; Blakeley JO; Sarin KY
J Invest Dermatol; 2023 Aug; 143(8):1358-1368. PubMed ID: 37245145
[TBL] [Abstract][Full Text] [Related]
6. KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth.
Anastasaki C; Dahiya S; Gutmann DH
Oncotarget; 2017 Jul; 8(29):47574-47585. PubMed ID: 28548933
[TBL] [Abstract][Full Text] [Related]
7. The NF1 gene in tumor syndromes and melanoma.
Kiuru M; Busam KJ
Lab Invest; 2017 Feb; 97(2):146-157. PubMed ID: 28067895
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and therapies for metastatic sarcoma.
Amankwah EK; Conley AP; Reed DR
Clin Epidemiol; 2013; 5():147-62. PubMed ID: 23700373
[TBL] [Abstract][Full Text] [Related]
9. Skin-derived precursor cells as an in vitro modelling tool for the study of type 1 neurofibromatosis.
Gutiérrez-Rivera A; Iribar H; Tuneu A; Izeta A
Stem Cells Int; 2012; 2012():646725. PubMed ID: 22550514
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.
Laycock-van Spyk S; Thomas N; Cooper DN; Upadhyaya M
Hum Genomics; 2011 Oct; 5(6):623-90. PubMed ID: 22155606
[TBL] [Abstract][Full Text] [Related]
11. The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.
Wu X; Chen S; He Y; Rhodes SD; Mohammad KS; Li X; Yang X; Jiang L; Nalepa G; Snider P; Robling AG; Clapp DW; Conway SJ; Guise TA; Yang FC
PLoS One; 2011; 6(9):e24917. PubMed ID: 21980365
[TBL] [Abstract][Full Text] [Related]
12. Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH.
Garcia-Linares C; Fernández-Rodríguez J; Terribas E; Mercadé J; Pros E; Benito L; Benavente Y; Capellà G; Ravella A; Blanco I; Kehrer-Sawatzki H; Lázaro C; Serra E
Hum Mutat; 2011 Jan; 32(1):78-90. PubMed ID: 21031597
[TBL] [Abstract][Full Text] [Related]
13. Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms.
Tartaglia M; Gelb BD
Ann N Y Acad Sci; 2010 Dec; 1214():99-121. PubMed ID: 20958325
[TBL] [Abstract][Full Text] [Related]
14. Water-clear cell parathyroid adenoma causing primary hyperparathyroidism in a patient with neurofibromatosis type 1: report of a case.
Kodama H; Iihara M; Okamoto T; Obara T
Surg Today; 2007; 37(10):884-7. PubMed ID: 17879040
[TBL] [Abstract][Full Text] [Related]
15. Somatic alterations of the NF1 gene in an NF1 individual with multiple benign tumours (internal and external) and malignant tumour types.
Spurlock G; Griffiths S; Uff J; Upadhyaya M
Fam Cancer; 2007; 6(4):463-71. PubMed ID: 17551851
[TBL] [Abstract][Full Text] [Related]
16. Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR.
Rübben A; Bausch B; Nikkels A
Mol Cancer; 2006 Sep; 5():36. PubMed ID: 16961930
[TBL] [Abstract][Full Text] [Related]
17. Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.
Yang FC; Chen S; Clegg T; Li X; Morgan T; Estwick SA; Yuan J; Khalaf W; Burgin S; Travers J; Parada LF; Ingram DA; Clapp DW
Hum Mol Genet; 2006 Aug; 15(16):2421-37. PubMed ID: 16835260
[TBL] [Abstract][Full Text] [Related]
18. Double inactivation of NF1 in tibial pseudarthrosis.
Stevenson DA; Zhou H; Ashrafi S; Messiaen LM; Carey JC; D'Astous JL; Santora SD; Viskochil DH
Am J Hum Genet; 2006 Jul; 79(1):143-8. PubMed ID: 16773574
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
